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Objectives: There is a recent consensus proposal of “cognitive frailty” deﬁned by the presence of both
physical frailty and cognitive impairment in the absence of dementia. The relevance, validity, and uti-
lization of cognitive frailty, however, is presently unclear. We determine whether concurrent physical
frailty and cognitive impairment, compared with physical frailty alone substantially increased adverse
health outcomes (functional disability, hospitalization, poor quality of life [QOL], and mortality).
Design: Longitudinal study.
Setting: Population-based cohort (Singapore Longitudinal Ageing Study, SLAS).
Participants: Two thousand three hundred seventy-ﬁve Chinese Singaporeans aged 55 and above without
dementia and degenerative disorders.
Measurements: Theassociationsofphysical frailty (CardiovascularHealthStudycriteria: 0¼ robust,1-2¼pre-
frail, 3-5 ¼ frail) with and without cognitive impairment (mini-mental state examination<26) and adverse
outcomeswereestimated, controlling forage,gender, education, comorbidity, smoking, alcohol consumption,
depressive symptoms, baseline activities of daily living-instrumental and basic activities of daily living
disability or QOL score.
Results: Compared to robust noncognitively impaired individuals, physical pre-frailty with cognitive
impairment was associated with a twofold increased prevalence and incidence of functional disability, a
twofold increased incidence of poor QOL, and 1.8-fold increased mortality risks. Cognitively impaired
frail individuals stood out with 12- to 13-fold increased prevalence and incidence of functional disability,
a ﬁve- and 27-fold increased prevalence and incidence of low QOL, and a ﬁvefold increased mortality
risk. The estimated prevalence of physical frailty with cognitive impairment was 1.8%, and physical pre-
frailty with cognitive impairment was 8.9%.
Conclusion: Pre-frailty and frailty with impaired cognitive function, found in 10.7% of this dementia-free
population, was associated with an evidently high risk of adverse health outcomes.
 2016 AMDA e The Society for Post-Acute and Long-Term Care Medicine. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Frailty is a commonly recognized geriatric syndrome resulting in
adverse health outcomes including hospitalization, institutionaliza-
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L. Feng et al. / JAMDA 18 (2017) 252e258 253is a key component of frailty, which is widely deﬁned as a physical
phenotype using Cardiovascular Health Study criteria (CHS): shrink-
ing, weakness, slowness, fatigue, and inactivity.1 This physical
phenotype has shown strong predictive validity for adverse health
outcomes. Given the heterogeneous nature of frailty, cognitive
impairment (which is also associated with functional decline and
disability)4 is arguably a component of frailty.5e7 Research is needed
to determine the contribution of other clinical domains to frailty that
might improve the predictive value of the frailty phenotype. Recently,
an international consensus group has proposed the concept of
“cognitive frailty”8 as a heterogeneous cognitive condition character-
ized by the simultaneous presence of both physical frailty and
cognitive impairment, excluding concurrent dementia or other de-
mentias. There is uncertainty about the meaning, validity, relevance,
and utilization of cognitive frailty in the clinical setting.9 Empirical
support for the concept of cognitive frailty should derive from data
that show the close association of physical frailty and cognitive
impairment and its prognostic utility in predicting future risks of
adverse health outcomes, including cognitive, functional disability,
health service use, and mortality outcomes.
There is currently good evidence to show that physical frailty is
strongly associatedwith prevalent cognitive impairment anddementia
in cross-sectional studies10e13 and with subsequent cognitive decline
or development of mild cognitive impairment or dementia in some but
not all longitudinal studies.10,14e18 One study reported that cognitive
impairment incorporated into the physical frailty phenotype improved
considerably its predictive validity for noncognitive adverse outcomes
including disability, hospitalization, and mortality more than physical
frailty alone.10 We have recently reported that physical frailty was
associated with increased prevalence and incidence of cognitive
impairment, and coexisting physical frailty and cognitive impairment
conferred additionally greater risk of incident mild cognitive impair-
ment and dementia.19 In this study, we further analyzed data in this
population-based prospective cohort study (Singapore Longitudinal
Ageing Study, SLAS) to determine whether concurrent physical frailty
and cognitive impairment, compared with physical frailty alone, sub-
stantially increased the risk of mortality, functional disability, hospi-
talization, and impaired quality of life (QOL).
Methods
Participants
As previously detailed,20 the SLAS-1 is a population-based longitu-
dinal study of aging and health of community-dwelling older Singapor-
eans aged 55 and above, excluding individuals who were not able to
participate because of severe physical or mental disability. The cohort
members were ﬁrst recruited in 2003/2005, and completed 2 follow-ups
at approximately 3-year intervals up to December 31, 2009. Baseline data
included demographic, medical, behavioral, biological, psychosocial, and
neurocognitive characteristics collected from extensive questionnaire
interviews and assessments. The study was approved by the National
University of Singapore Institutional ReviewBoard, andwritten informed
consent was obtained from all participants.
We recruited at baseline 2804 older adults for the SLAS-1 cohort. In
this study, we excluded a small number of non-Chinese (n ¼ 193) and
those who reported a history of dementia, stroke, Parkinson’s disease,
other neurodegenerative disorders (n ¼ 133), and missing baseline
frailty score (n ¼ 73), Mini-Mental State Examination (MMSE) score
(n ¼ 3), physical function (n ¼ 20) smoking (n ¼ 3), as well as a Na-
tional Registration Identity Card number (n ¼ 4), resulting in 2375
Chinese older adults for cross-sectional analysis.
The longitudinal analyses for different adverse health outcomes
were based on various sample sizes given missing data on baseline
covariates and from follow-up loss:1. Mortality outcome: the analytic sample (N) comprised 2375
individuals.
2. Functional activities of daily living-instrumental and basic ac-
tivities of daily living (ADL-IADL) disability outcome: N ¼ 1207
individuals after excluding those with missing baseline
(n ¼ 20) and follow-up (n ¼ 849) physical function data,
baseline smoking status (n ¼ 1), and those with dependent
physical function at baseline (n ¼ 325).
3. Hospitalization outcome: N ¼ 1503 individuals, after excluding
participants missing follow-up hospitalization data (n ¼ 828),
baseline data on physical function (n ¼ 12), smoking status
(n ¼ 1), or hospitalized in the year prior to baseline (n ¼ 58).
4. Health-related QOL Short Form-12 (SF-12) physical component
score (PCS): N ¼ 1197 after excluding those without follow-up
SF-12 data (n ¼ 827), baseline data on SF-12 (n ¼ 4), physical
function (n ¼ 12), smoking status (n ¼ 1), and those with
baseline PCS lower than its lowest quartile (n ¼ 361).
Baseline Measurements
Physical frailty at baseline was assessed based on criteria used in
the CHS with operational modiﬁcations:
1. Shrinking was deﬁned as body mass index of <18.5 kg/m2 or
weight loss of 4 kg in the past 6 months.
2. Weakness was assessed by the Performance-Oriented Mobility
Assessment battery.21 Muscle weakness was assessed by per-
formance on rising from a chair in the sitting position with
arms folded. The summed score (range, 0-16) in the lowest
gender- and body mass index-adjusted quintile was used to
denote weakness and instability.
3. Slowness was determined with the subject walking 6 meters
and returning quickly to the starting point and denoted by gait
performance scores (range, 0-12) of less than 9.
4. Exhaustion was measured by one question from the SF-12 QOL
scale: “Do you have lots of energy?”22
5. Low activity was assessed by questions on the number and
frequencies of usual participation in 16 categories of activities
using the 3-point Likert scale for each activity, and low activity
was deﬁned as a total score below the lowest gender-adjusted
quintile.
Scores were assigned to each frailty component (1 ¼ present,
0 ¼ absent), and the summed scores were used to categorize subjects
as frail (score ¼ 3-5), pre-frail (score ¼ 1 or 2), and robust (score ¼ 0
points). This modiﬁed categorical measure of physical frailty has been
shown in previous studies to predict depression, ADL-IADL de-
pendency, hospitalization, and poor QOL.23
Cognitive impairment was determined using scores of the Chinese
version of the Mini-Mental State Examination (CMMSE), with total
scores ranging from 0 to 30 (higher score indicating better cognition).
The CMMSE has been validated for local use in Singaporean older
adults, and a score of<26 denotes mild or greater degrees of cognitive
impairment.24
Outcome Measurements
1. Functional disability was assessed by self-reportedmeasures of
IADL and ADL.25,26 Participants were classiﬁed as having any
IADL or ADL disability and as no IADL or ADL disability.
2. QOL was measured using the Medical Outcomes Study SF-12
PCS of QOL.22 Poor QOL was deﬁned by the PCS score below
the lowest quartile in the distribution.
3. Hospitalization was determined by the participants’ self-
reports of new hospitalizations for any chronic medical con-
ditions over the previous year.
Table 1
Baseline Characteristics of Chinese Older Adults (n ¼ 2375)
Variables Total
N ¼ 2375
Robust
N ¼ 1552 (%)
Pre-frail
N ¼ 792 (%)
Frail
N ¼ 61 (%)
P
Value
Cognitive impairment (MMSE < 26) 476 (20.0) 221 (14.5) 212 (26.8) 43 (70.5) <.001
Age, mean (SD) years 65.8 (7.46) 64.2 (6.26) 68.0 (8.31) 75.3 (8.76) <.001
Male 860 (36.2) 538 (35.4) 298 (37.6) 24 (39.3) .49
Education <.001
Primary or below 1231 (51.8) 694 (45.6) 480 (60.6) 57 (93.4)
Secondary or above 1144 (48.2) 828 (54.4) 312 (39.4) 4 (6.6)
Current smoking (vs. others) 147 (6.2) 66 (4.3) 72 (9.1) 9 (14.8) <.001
Alcohol consumption 270 (11.4) 199 (13.1) 67 (8.5) 4 (6.6) .002
Comorbidity, mean (SD) 2.2 (1.39) 2.1 (1.31) 2.4 (1.45) 3.0 (1.91) <.001
APOE epsilon4 carrier 392 (16.5) 259 (17.0) 124 (15.7) 9 (14.8) .66
Depressive symptoms (GDS  5) 303 (12.8) 149 (9.8) 131 (16.5) 23 (37.7) <.001
MMSE score, mean (SD) 27.2 (3.13) 27.7 (2.44) 26.5 (3.52) 22.1 (5.87) <.001
ADL-IADL disability 534 (22.5) 230 (15.1) 259 (32.7) 45 (73.8) <.001
Hospitalization in the past year 82 (3.5) 47 (3.1) 30 (3.8) 5 (8.2) .082
Below lowest quartile of PCS 12 577 (24.3) 295 (19.4) 240 (30.4) 42 (68.9) <.001
ANOVA, analysis of variance; ADL-IADL, activities of daily living- instrumental activities of daily living; GDS, Geriatric Depression Scale; MMSE, Mini-Mental State Exami-
nation; SD, standard deviation.
Signiﬁcance tests: ANOVA for continuous variables or Cochran-Mantel-Haenszel test for categorical variables.
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May 2014 was obtained by record linkage with the National
Death Registry of Singapore through the National Disease
Registry Ofﬁce of the Ministry of Health.
Other Variables
Sociodemographic data included age, gender, and education.
Medical comorbidity was determined by responses to a checklist of
whether the patients had a doctor’s diagnosis and treatment for each
of 16 speciﬁc or other medical condition(s) (depression excluded) in
the past year and estimating the total number of medical conditions.
Lifestyle variables included self-reports of current smoking and daily
alcohol consumption. Depressive symptoms were determined by the
Geriatric Depression Scale (GDS), which has been validated for use in
local Chinese, Malay, and Indian subjects.27 The presence of depressive
symptoms was denoted by a GDS score of 5 or above.
Statistical Analysis
We performed cross-sectional and longitudinal analyses of the
associations of frailty with adverse outcome variables using logistic
regression for ADL-IADL disability, hospitalization and low QOL out-
comes, and Cox-regression analyses for mortality outcomes. We
estimated odds ratios (ORs) or hazard ratios (HRs) of association and
their 95% conﬁdence intervals (95% CIs) for categories of frailty and
cognitive impairment: (1) robust without cognitive impairment, (2)
robust with cognitive impairment, (3) pre-frail without cognitiveTable 2
Cross-Sectional and Longitudinal Analyses of Associations of Baseline Physical Frailty Sta
ADL-IADL Disability Past Year Hospitalization
OR (95% CI) P
Value
OR (95% CI) P
V
Cross-sectional
analyses
N ¼ 2375 N ¼ 2375
Robust 230/1522 1.00 47/1522 1.00
Pre-frail 259/792 1.96 (1.57-2.46) <.001 30/792 1.02 (0.62-1.70) .
Frail 45/61 6.33 (3.31-12.1) <.001 5/61 1.32 (0.42-4.16) .
Longitudinal
analysis
N ¼ 1207 N ¼ 1503
Robust 69/861 1.00 62/1010 1.00
Pre-frail 46/337 1.38 (0.91-2.11) .13 44/468 1.44 (0.94-2.20) .
Frail 5/9 7.21 (1.72-30.3) .007 5/25 2.69 (0.88-8.26) .impairment, (4) pre-frail with cognitive impairment, (5) frail without
cognitive impairment, and (6) frail with cognitive impairment. Esti-
mated ORs and HRs were adjusted as appropriate for age, gender,
education, medical comorbidity, current smoking, alcohol consump-
tion, depressive symptoms, and as appropriate baseline ADL-IADL
disability, baseline PCS score (for PCS as outcome). A two-sided P
value of .05 was considered as statistically signiﬁcant in the study. All
analysis was performed using SAS 9.2 (SAS Institute, Inc., Cary, NC).
Results
The mean age of the study sample was 65.8 (7.46 SD), 63.8% were
female, 51.8% had primary or lower education, and 20% had cognitive
impairment at baseline. About 2.6%were frail, 33.4% pre-frail, and 64.1%
robust overall. Cognitive impairment was present in 15% of robust, 27%
of pre-frail, and 70% of frail participants. The baseline characteristics
and follow-up outcomes for robust, pre-frail, and frail categories are
shown in Table 1. Compared with robust participants, those who were
pre-frail and frail were older, had a lower education level, a higher
proportion of current smokers but a lower proportion of current
drinkers. They also had more medical comorbidities and greater prev-
alence of cognitive impairment and depressive symptoms at baseline.
Physical Frailty and Adverse Health Outcomes
The associations between physical frailty (robust, pre-frailty and
frailty) and prevalent adverse health status from cross-sectional an-
alyses are shown in Table 2. Compared to being robust, being pre-frailtus and Prevalent and Follow-up Adverse Outcomes
Lowest Quartile of PCS-12 Mortality
alue
OR (95% CI) P HR
(95%CI)
P
N ¼ 2371 NA
295/1520 1.00 NA
93 240/790 1.41 (1.13-1.76) .002 NA
64 42/61 4.82 (2.53-9.19) <.001 NA
N ¼ 1197 N ¼ 2375
126/839 1.00 108/1522 1.00
053 90/345 1.66 (1.20-2.30) .002 119/792 1.26 (0.95-1.68) .108
094 8/13 6.27 (1.91-20.6) .002 30/61 2.56 (1.56-4.19) <.001
Table 3
Associations of Baseline Coexisting Physical Frailty and Cognitive Impairment With Prevalent and Follow-Up Adverse Health Events
ADL-IADL Disability Past Year Hospitalization Lowest Quartile of PCS-12 Mortality
OR (95% CI) P Value OR (95% CI) P
Value
OR (95% CI) P HR (95%CI) P
Cross-sectional analyses N ¼ 2375 N ¼ 2375 N ¼ 2371
Robust without cognitive impairment 200/1301 1.00 43/1301 1.00 253/1299 1.00
Robust with cognitive impairment 30/221 0.74 (0.47-1.15) .18 4/221 0.59 (0.20-1.74) .34 42/221 0.74 (0.50-1.10) .14
Pre-frail without cognitive
impairment
169/580 1.77 (1.38-2.27) <.001 22/580 0.98 (0.57-1.71) .95 167/578 1.37 (1.07-1.75) .013
Pre-frail with cognitive impairment 90/212 2.43 (1.69-3.49) <.001 8/212 0.91 (0.38-2.17) .83 73/212 1.24 (0.85-1.80) .26
Frail without cognitive impairment 9/18 2.75 (1.00-7.58) .050 0/18 Not estimated 10/18 2.96 (1.05-8.31) .040
Frail with cognitive impairment 36/43 12.6 (5.25-30.4) <.001 5/43 1.74 (0.54-5.57) .35 32/43 5.34 (2.42-11.77) <.001
Robust (with or without cognitive
impairment)
230/1552 1.00 47/1522 1.00 295/1520 1.00
Pre-frail or frail without cognitive
impairment
178/598 1.87 (1.47-2.38) <.001 22/598 1.00 (0.58-1.2) .99 177/596 1.45 (1.15-1.84) .002
Pre-frail or frail with cognitive
impairment
126/255 3.22 (2.32-4.47) <.001 13/255 1.22 (0.58-2.59) .60 105/255 1.62 (1.16-2.27) .005
Longitudinal analyses* N ¼ 1207 N ¼ 1503 N ¼ 1197
Robust without cognitive impairment 54/742 1.00 51/872 1.00 105/722 1.00 81/1301 1.00
Robust with cognitive impairment 15/119 1.43 (0.73-2.80) .29 11/138 1.55 (0.75-3.21) .24 21/117 0.82 (0.47-1.42) .47 27/221 1.70 (1.07-2.71) .025
Pre-frail without cognitive
impairment
30/262 1.37 (0.84-2.24) .21 35/351 1.63 (1.02-2.59) .040 59/264 1.42 (0.98-2.07) .066 73/580 1.40 (1.00-1.94) .048
Pre-frail with cognitive impairment 16/75 2.04 (1.00-4.14) .049 9/117 1.31 (0.59-2.95) .51 31/81 2.24 (1.29-3.87) .004 46/212 1.83 (1.20-2.79) .005
Frail without cognitive impairment 2/4 5.46 (0.69-43.3) .109 2/9 4.67 (0.89-24.4) .068 2/6 1.72 (0.29-10.03) .547 4/18 1.49 (0.53-4.20) .45
Frail with cognitive impairment 3/5 12.2 (1.69-88.5) .013 3/16 2.40 (0.59-9.78) .22 6/7 26.9 (3.05-238.4) .003 26/43 5.12 (3.00-8.74) <.001
Robust (with or without cognitive
impairment)
69/861 1.00 62/1010 1.00 126/839 108/1522 1.00
Pre-frail or frail without cognitive
impairment
32/266 1.32 (0.83-2.09) .24 37/360 1.56 (1.01-2.42) .048 61/270 1.47 (1.03-2.11) .034 77/598 1.21 (0.89-1.64) .22
Pre-frail or frail with cognitive
impairment
19/80 2.06 (1.09-3.92) .027 12/133 1.27 (0.62-2.61) .52 37/88 2.78 (1.67-4.62) <.001 72/183 1.92 (1.34-2.74) <.001
ADL, activities of daily living; IADL, instrumental activities of daily living; OR, odds ratio; PCS, physical component score; HR, hazard ratio; SF-12, Short Form-12; 95% CI, 95% conﬁdence interval.
Cognitive impairment was denoted byMMSE<26. Adjusted for age, gender, education, medical comorbidity, current smoking, alcohol drinking, depressive symptoms, baseline ADL-IADL disability, baselineMMSE score, baseline
PCS score (for PCS as outcome).
*Longitudinal analysis were restricted to subjects without baseline ADL-IADL disability or low PCS or hospitalization for respective outcomes.
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L. Feng et al. / JAMDA 18 (2017) 252e258256and frail were associated with increased ORs (between 1.41 and 6.33)
for prevalent disability and low QOL, but not for hospitalization in the
past year. In longitudinal analyses, frail participants compared to
robust participants were signiﬁcantly more likely to subsequently
report disability (OR, 7.21; 95% CI, 1.72-30.3), poor QOL (OR, 6.27; 95%
CI, 1.91-20.6), and to die earlier (HR, 2.56; 95% CI, 1.56-4.19). Pre-frailty
was associated with moderately elevated risks of incident adverse
events (ORs ranging from 1.38 to 1.66), which was signiﬁcant for only
poor QOL (OR, 1.66; 95% CI, 1.20-2.30).Physical Frailty with Cognitive Impairment and Adverse Health
Outcomes
Table 3 shows the results of cross-sectional and longitudinal ana-
lyses (also in Figure 1) of the associations between subcategories of
physical frailty with and without cognitive impairment (MMSE < 26)
and adverse health outcomes, using robust and noncognitively
impaired participants as the reference group.ADL-IADL Disability
In cross-sectional and longitudinal analyses, the estimates of ORs
were increased for pre-frailty without cognitive impairment:
OR ¼ 1.77 (95% CI, 1.38-2.27) for prevalent disability and OR ¼ 1.37
(95% CI, 0.84-2.24) for incident disability, and frailty without cognitive
impairment: OR ¼ 2.75 (95% CI, 1.00-7.58) for prevalent disability and
OR ¼ 5.46 (95% CI, 0.69-43.3) for incident disability. The estimates of
increased ORs were much greater in the presence of cognitive
impairment, for pre-frailty with cognitive impairment: OR¼ 2.43 (95%
CI, 1.69-3.49) for prevalent disability and OR ¼ 2.04 (95% CI, 1.00-4.14)
for incident disability, and frailty with cognitive impairment:
OR ¼ 12.6 (95% CI, 5.25-30.4) for prevalent disability, and OR ¼ 12.2
(95% CI, 1.69-88.5) for incident disability.Fig. 1. Estimates of associations of baseline combined physical frailty anQuality of Life
In both cross-sectional and longitudinal analyses, similar patterns of
associations of poor QOLwith subcategories of physical frailty with and
without cognitive impairment were observed. Frailty with cognitive
impairment inparticularwasmost strongly associatedwithpoorQOL at
baseline (OR, 5.34; 2.42-11.7) and fromfollow-up (OR, 26.9; 3.05-238.4).
Regarding hospitalization, in cross-sectional and longitudinal an-
alyses, inconsistent trends of ORs of association across subcategories
of physical frailty with and without cognitive impairment were
observed.Mortality
Compared to being robust without cognitive impairment, being
pre-frail without cognitive impairment (HR, 1.40; 95% CI, 1.00-1.94)
and frail without cognitive impairment (HR, 1.49; 95% CI, 0.53-4.20)
were associated with an approximate 50% increased risk of dying.
Being pre-frail with cognitive impairment was associated with an 80%
greater risk of dying (HR, 1.83, 95% CI; 1.20-2.79), but frailty with
cognitive impairment was associated with a ﬁvefold increased risk of
death (HR, 5.12; 95% CI, 3.00-8.74).Discussion
Previous studies have shown that the physical frailty phenotype
predicted an increased risk of cognitive decline and dementia.9,13,14
Likewise, we have previously shown that coexisting physical frailty
and cognitive impairment conferred an additionally greater risk of
prevalent and incident mild cognitive impairment and dementia.19 In
this study, we showed that frail and pre-frail individuals with cogni-
tive impairment compared to their cognitively normal counterparts
were more likely to have a substantially higher prevalence and inci-
dence of functional disability, poorer QOL, and mortality. In particular,d cognitive impairment status with incident adverse health events.
L. Feng et al. / JAMDA 18 (2017) 252e258 257those who were cognitively impaired and frail (cognitive frail) stood
out for their 12-fold increased prevalence and incidence of functional
disability, ﬁve- and 27-fold increased prevalence and incidence of low
QOL status, and ﬁvefold increased mortality risk. Cognitive pre-frailty
was also associated with a twofold increased prevalence and inci-
dence of functional disability, a twofold increased incidence of low
QOL status, and a 1.8-fold increase in mortality risks.
Our study corroborates prior ﬁndings from the Three-City Study10
and suggests that adding cognitive impairment to the operational
criteria deﬁning the frailty phenotype could improve the deﬁnition and
increase its predictive validity with regard to adverse health outcomes.
In that study, cognitively impaired frail persons showed a signiﬁcantly
increased risk of developing dementia and functional disability and a
marginally greater risk of incident hospitalization, but no signiﬁcant
increase in mortality, although there was a positive trend in mortality
across cognitively impaired robust, pre-frail, and frail groups.
Semantically, the combination of physical frailty and cognitive
impairment needs to be more clearly understood. It is widely accepted
that frailty is broadly characterized by loss of physiological reserve
involving multiple systems. Cognitive impairment is logically a
component of frailty, and in accord with the cumulative deﬁcit model,
is operationalized as a component of the Frailty Index (FI).5 The
addition of cognitive impairment to the physical frailty phenotype
thus incorporates the loss of brain and cognitive functioning reserve in
the frailty deﬁnition. At the same time, the simultaneous presence of
both physical frailty and cognitive impairment, excluding concurrent
dementia or other dementias has been labelled as cognitive frailty by
an international consensus group.7 As such, cognitive frailty is
conceived as a heterogeneous cognitive condition that results from
physical frailty per se and not from a known neurodegenerative dis-
order, and thus, it is regarded as a premorbid entity predicting the risk
of dementia. As participants with neurodegenerative disorders and
dementia were excluded in this study, pre-frail and frail individuals
with cognitive impairment may be considered representative of the
cognitive frailty phenotype. At the same time, individuals with both
physical frailty and cognitive impairment may be viewed as repre-
senting a subset of frail older persons who are most vulnerable to
adverse outcomes including dementia, functional disability, and death.
The clinical utility and relevance of our ﬁndings should be assessed
in relation to the population prevalence of physical frailty and pre-
frailty with cognitive impairment. In this population of community-
living older persons, approximately 3% and 33% of the participants
were frail and pre-frail. Approximately 70% of frail and 27% of pre-frail
individuals were cognitively impaired, considerably more than the
15% among robust individuals. The estimated prevalence of coexisting
physical frailty and cognitive impairment in this population of older
adults without dementia was 1.8%, and physical pre-frailty with
cognitive impairment was 8.9%. Given the demonstrable risk of
adverse health outcomes associated with physical pre-frailty and
frailty with cognitive impairment, potentially a total of 10.7% of the
population who are pre-frail or frail and cognitively impaired should
be considered as one target group for special intervention. Physical
and cognitive frailty are potentially reversible, and research in this
direction should provide evidence-based guidance to prevent de-
mentia, functional decline, and premature deaths.
Conclusion
The study has some limitations. We used criteria to deﬁne frailty
that differ slightly from the ones originally used (eg, the use of a
self-reported measure of strengthddifﬁculty rising from a chair
instead of the hand grip or lower limb strength). We have shown in
another (SLAS-2) cohort that also measured limb strength that both
the original and modiﬁed CHS scale demonstrated reasonable agree-
ment (weighted kappa of 0.63) and were equally predictive of adversehealth outcomes with comparable areas under the curve in receiver
operating characteristic ROC analyses.19 As hospitalization outcome
datawere based on self-reports of hospitalization episodes and not on
electronic hospitalization record linkage, they may not be sufﬁciently
reliable. A MMSE score of 26 as the cut point could overestimate the
prevalence of cognitive impairment, slightly biasing the results away
from the null. Because participants who were lost to follow-up more
likely were males, had more comorbidities, functional disability,
depressive symptoms, and were more cognitively impaired, the study
may be biased by selecting those who were healthier at baseline, and
this may possibly weaken the predictive validity for nonfatal
outcomes.
In conclusion, physical pre-frailty and frailty concurrent with
cognitive impairment found in 10.7% of this dementia-free population
was associated with evidently high risk of adverse health outcomes.References
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